tyropanoate has been researched along with Graves Disease in 1 studies
Tyropanoate: A diagnostic aid as a radiopaque medium in cholecystography.
Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noguchi, K | 1 |
| Suzuki, H | 1 |
| Nakahata, M | 1 |
| Kurosawa, S | 1 |
| Nakagawa, S | 1 |
1 other study available for tyropanoate and Graves Disease
| Article | Year |
|---|---|
Prolonged treatment of hyperthyroidism with sodium tyropanoate, an oral cholecystographic agent: a re-evaluation of its clinical utility.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Iodobenzenes; Male; Methimazole; M | 1986 |